Android app on Google Play

AVEO Pharma (AVEO) Sees IPO Price of $13 - $15

February 23, 2010 11:48 AM EST Send to a Friend
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) has filed an amended registration statement with the SEC for an initial public offering of its common stock. The Company is offering 7,000,000 shares and expects the offering price to be between $13 - $15 per share. The Company plans to list on the NASDAQ Global Market under the symbol "AVEO".

The offering is being made through J.P. Morgan and Morgan Stanley.

AVEO is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics. Their product candidates are directed against important mechanisms, or targets, known or believed to be involved in cancer.



You May Also Be Interested In


Related Categories

IPOs

Related Entities

JPMorgan, Morgan Stanley

Add Your Comment